September 23, 2020 09:42 AM EDTUpdated September 24, 03:37 AM

Covid-19 roundup: J&J begins pivotal Phase III trial for vaccine; Controversial human challenge trials to begin in London — report

Nicole DeFeudis

Editor

Amber Tong

Johnson & Johnson announced it’s beginning a pivotal Phase III trial for its Covid-19 candidate, JNJ-78436735 — the first single-dose vaccine in this stage. …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Covid-19 roundup: J&J begins pivotal Phase III trial for vaccine; Controversial human challenge trials to begin in London — report

Nicole DeFeudis

Editor

Amber Tong

Sign up to read this article for free.

Novartis to cut 139 jobs in NJ as part of commercial refocus

PTC reports Phase 2 ALS fail, sells priority review voucher for $150M

To lead NIH, Trump taps Stanford academic and pandemic response critic Jay Bhattacharya

Norbert Bischofberger's time as Kronos CEO ends as biotech seeks new life

Advanz Pharma faces revocation of European authorization for liver disease drug Ocaliva

Bristol Myers sues the federal government over 340B, following other drugmakers

Covid-19 roundup: J&J be­gins piv­otal Phase III tri­al for vac­cine; Con­tro­ver­sial hu­man chal­lenge tri­als to be­gin in Lon­don — re­port

Editor

Sign up to read this article for free.

more like this

Covid-19 roundup: J&J begins pivotal Phase III trial for vaccine; Controversial human challenge trials to begin in London — report